Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Adamas Pharmaceuticals Inc

TRADE

NASDAQ: ADMSHealthcare / Drugs - Generic / USA
25.21-0.29-1.14%Vol 998 0541Y Perf 49.58%
Jun 22nd, 2018 16:00
BID25.19 ASK27.45
Open25.63 Previous Close25.50
Pre-Market- After-Trading25.21
 - -%  - -%
Target Price
48.14 
Analyst Rating
Strong Buy 1.00
Potencial %
90.96 
Finscreener Ranking
★★★     50.43
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
★★     44.18
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)680 
Earnings Rating
Sell
Price Range Ratio 52wk %
38.39 
Earnings Date
14th Aug 2018

Today's Price Range

24.6125.70

 

52wk Range

13.5044.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-14.05%
3 Months
5.84%
6 Months
-26.72%
1 Year
49.58%
3 Years
-3.26%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ADMS25.21-0.2900-1.14
AAPL184.92-0.5400-0.29
GOOG1 155.48-2.1800-0.19
MSFT100.41-0.7300-0.72
XOM81.381.69002.12
WFC53.94-0.4300-0.79
JNJ122.841.39001.14
FB201.740.24000.12
GE13.050.29002.27
JPM105.75-1.7600-1.64
...

TickerPriceChg.%52 Week High
KMX80.1912.8681.67
MRO21.487.8322.12
APC74.116.6974.72
PCG42.925.9071.57
PDCO24.625.7648.29
NFX30.755.2035.20
DVN43.285.1845.16
FTI32.345.1435.00
HES64.574.6365.89
PXD185.654.29213.40
XEC97.694.18130.16
COP67.784.1071.71
SWN5.473.806.72
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 9.60
Current Ratio 9.90
Long Term Debt to Total Capital 0.39
Total Debt to Equity 0.63
Interest Coverage -10.60
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin98.70
EBIT Margin-3 223.20
EBITDA Margin-3 181.80
Pre-tax Profit Margin-5 873.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 4.16
PS Ratios 225.60
Price to Cash Flow 23.20
Price to Free Cash Flow -8.90
Cash Flow Per Share -3.31
Price to Tangible Book4.16
Book Value per Share6.29
Enterprise Value (in ths.)613 353
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-31.75
ROE last 12 Months -70.37
Return on Assets (5Y Avg) -14.88
ROA last 12 Months -48.51
Return on Capital (5Y Avg) -1.24
ROC last 12 Months -40.11
Return on invested Capital Q -13.93
Return on invested Capital Y-42.74
Assets Turnover0.00
Receivables Turnover2.30
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)3 124
Revenue per Share 0.12
Revenue Growth 3 Years -64.58
Revenue Growth 5 Years -59.60
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-1.38-1.352.17
Q04 2017-1.15-1.27-10.43
Q03 2017-1.03-1.04-0.97
Q02 2017-0.85-0.93-9.41
Q01 2017-0.72-0.720.00
Q04 2016-0.82-0.6817.07
Q03 2016-0.85-0.6622.35
Q02 2016-0.69-0.78-13.04
Earnings Per EndEstimateRevision %Trend
6/2018 QR-1.44-8.27Negative
9/2018 QR-1.48-5.71Negative
12/2018 FY-5.79-4.70Negative
12/2019 FY-4.01-34.56Negative
Next Report Date14th Aug 2018
Estimated EPS Next Report-1.44
Estimates Count4
EPS Growth Next 5 Years %37.70
Volume Overview
Volume998 054
Shares Outstanding (in ths.)26 980
Trades Count2 577
Dollar Volume22 351 297
Avg. Volume871 215
Avg. Weekly Volume511 068
Avg. Monthly Volume536 392
Avg. Quarterly Volume667 773

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

76%24%

Bearish Bullish

58%42%

Bearish Bullish

57%43%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
9 (100.00 %)
9 (100.00 %)
8 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x